about
Liver transplantation for viral hepatitis in 2015Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionTherapeutic approaches for portal biliopathy: A systematic reviewMarkers of acute rejection and graft acceptance in liver transplantationSpontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.Current challenges and future directions for liver transplantation.Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients.New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation.Recent advances in understanding and managing liver transplantationObliterative portal venopathy without portal hypertension: an underestimated condition.Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma.Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service.Quality of life and adherence in liver transplant recipients.Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study.An untreatable dyspnoea: more defendants under investigation.Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?Acute alcoholic hepatitis and liver transplantation: Waiting for Godot.Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.Management of bacterial infection in the liver transplant candidate.Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis.Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites.Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center studyHepatitis B and liver transplantationSuccessful pregnancy in Alagille SyndromeBeta-blockers in cirrhosis: therapeutic window or an aspirin for all?Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLFMortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysisAntibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with careOutcomes of Liver Transplant for Adults With Wilson's DiseaseAllocation of liver grafts worldwide - Is there a best system?Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting
P50
Q26773224-B01B3303-D57A-4E58-9669-B19D4B0AAEC0Q28069136-8427215D-EEE1-4924-9AB1-5A2645F84DDAQ28073479-C914FBD4-C56D-4C6B-9AE4-13ECC4726693Q28088272-1A581D04-63A9-4554-BFE5-D32ABCFC5862Q33424708-F4ADF096-0DE5-44CC-A82E-8837C016BFABQ38213956-CAFA01FA-AF5E-4EB1-866D-9A0482A6364BQ38763789-F76CD11B-457A-43B9-9A4A-280BE51A2C72Q38820685-FD29B93F-AF1E-45DE-B7EB-4EB516B9E2D6Q38928403-742D5929-7427-4DCE-8D85-8B42D1551107Q38980269-0C9C7091-724B-4012-B596-F62BB7959382Q39095917-31622AF3-A11C-472B-9926-DDFA7409BE58Q41492494-C8CB9C8B-CB9A-4210-8E4C-DF35D2AC86CDQ45863835-CA6ED23D-0D15-4389-9089-806826AD3512Q47200521-F552D2AA-9DAF-4308-AA23-616E7E11CD87Q47605308-BFC46C25-570C-4BD8-AEBD-4665D4D7A03CQ47786226-50DC23F6-864C-4D27-ADA5-2DF4BD9A62CAQ47974675-B1CC2AE9-3ADA-4392-B7AC-E7B70EA84714Q48088418-F5CA2884-354D-4D07-AE7A-FADE9D38658FQ48169596-2394CB6F-8CAB-45D7-AA32-EAC9D58F8481Q53092609-A361E878-9757-4104-A660-5544A35EF385Q53703034-90CE3937-4096-45A0-BC96-034CD8A30A76Q53780737-820876E7-E169-4DDF-B18C-D1097C3F9D14Q55346249-BFC70B8A-C169-4BFF-A815-77D936F56620Q57815092-31AACC31-8AD5-407C-83B7-9CC091A133A6Q59351994-A3AFF249-D6A6-46DD-A36E-7D62896641FAQ85642591-1B1E6E83-4A82-4577-AC92-0186D34506ACQ87759605-B043BE1A-9BF8-4B9C-8657-0F35FE1F853CQ91235790-6C2FEF08-59D5-4151-8DA9-B55827ADB94EQ91533244-73F1851B-E7A0-46B2-870C-E5A28A1A32D7Q91619706-AC4657F2-F43C-4B06-85A3-E2C414EF7428Q92412845-39FFAA39-7C77-46CE-80F1-C9CBF8DFDE97Q92752403-66F72A71-48E4-4F5C-8E19-3CCFAB4A38AEQ92992255-760A6B93-2A20-4A42-A962-B4C4F372FBD7
P50
description
investigador
@es
researcher
@en
name
Alberto Ferrarese
@en
type
label
Alberto Ferrarese
@en
prefLabel
Alberto Ferrarese
@en
P31
P496
0000-0002-3248-2038